Industry News
Sight Sciences Supports Royal College of Ophthalmologists MIGS Course.
Sight Sciences were pleased to take part in the inaugural Minimally Invasive Glaucoma Surgery (MIGS) course at the Royal College of Ophthalmologists in London on 16 January. Organised by Mr. Ahmad Elsahn, the event brought together renowned glaucoma specialists from...
BBC News Highlights New Approach to Treating Ocular Hypotony
Ocular hypotony has been in the spotlight following recent BBC News coverage highlighting how new clinical research is delivering meaningful benefits for patients affected by this sight threatening condition. The feature draws attention to a newly published study from the...
From Dye to Digital: Why OCTA is replacing invasive imaging in retinal care
For decades, retinal imaging has relied on invasive dye based techniques to visualise the eye’s vasculature. However, Optical Coherence Tomography Angiography (OCTA) is fast becoming the preferred modality, replacing fluorescein and ICG angiography in many clinical settings. As highlighted by...
MacuMira and Keeler announce strategic partnership to expand dry AMD therapy
Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...
Buy Tonosafe directly from Haag-Streit UK
Earlier this year Haag-Streit UK announced that it would no longer be working with NHS supply chain. In order to provide a more flexible and transparent procurement process, products, including Tonosafe disposable prisms, are now being supplied directly to NHS...
Haag-Streit Academy announces course schedule for 2026
The full schedule for Haag-Streit Academy’s popular educational courses has been announced for 2026 and dates are now available to book. The schedule includes the usual basic and advanced slit lamp courses along with ‘Improving Outcomes’ biometry courses and will...
A helping hand from Altomed
Your training journey is important and Altomed is here to help you build skills with confidence. That’s why, for a short time only, we’re offering a Buy 2, Get 1 Free promotion on 4 SimulEYE models (see website for full...
Eye Juniors Introduction to the ST1 Application 2025-26
Join Eye Juniors for their Introduction to ST1 Ophthalmology Application 2025-2026. In this free talk high scoring trainees will talk you through the entire ST1 application process – from the MSRA and portfolio to the interview. They’ve been running the...
Biotech Healthcare unveils Optiflex XTENSE Comfort Plus at ESCRS 2025 (Copenhagen), marking a new era in Full Visual Range EDOF IOLs
Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation...
Haag-Streit announces global launch of Elara 900 and Refractor 900 at ESCRS 2025
Bishop’s Stortford, UK – 12th September 2025 – Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is proud to announce the global launch of two new innovations:...
Heidelberg Engineering Celebrates Eye2Gene™ AI Breakthrough in Precision Ophthalmology
Heidelberg Engineering proudly announces a significant advance in the use of artificial intelligence for ophthalmic diagnostics, with the publication of the Eye2Gene™ study in Nature Machine Intelligence. Titled “Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene”, the...
Glaukos Launches iStent infinite® in the UK Following MDR Approval
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...
